Display Settings:

Format

Send to:

Choose Destination
    Clin J Oncol Nurs. 2007 Dec;11(6):901-13.

    Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy.

    Source

    The College of Nursing, The University of Nebraska Medical Center, Omaha, NE, USA. cvisovsky@unmc.edu

    Abstract

    Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a significant, debilitating symptom resulting from the administration of neurotoxic chemotherapy for the treatment of cancer. CIPN is an important consequence of cancer treatment because of its potential impact on physical functioning and quality of life. Oncology nurses play an important role in assessing, monitoring, and educating clients about CIPN. Despite investigations concerning pharmacologic and nonpharmacologic approaches to either preventing or minimizing the neurotoxicity resulting from certain chemotherapeutic agents, evidence to support the interventions is lacking. This article presents information concerning CIPN and summarizes the evidence for pharmacologic and nonpharmacologic approaches to the prevention and treatment of CIPN.

    PMID:
    18063548
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for MetaPress.com

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk